Fagron NV (EBR:FAGR)

Belgium flag Belgium · Delayed Price · Currency is EUR
20.50
+0.20 (0.99%)
Apr 30, 2025, 5:35 PM CET
Market Cap 1.49B
Revenue (ttm) 871.96M
Net Income (ttm) 80.55M
Shares Out 72.84M
EPS (ttm) 1.10
PE Ratio 18.64
Forward PE 15.14
Dividend 0.35 (1.71%)
Ex-Dividend Date May 21, 2024
Volume 85,624
Average Volume 65,428
Open 20.35
Previous Close 20.30
Day's Range 20.30 - 20.55
52-Week Range 15.14 - 20.55
Beta 0.25
RSI 67.20
Earnings Date Jul 31, 2025

About Fagron NV

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointest... [Read more]

Sector Healthcare
Founded 1990
Employees 3,828
Stock Exchange Euronext Brussels
Ticker Symbol FAGR
Full Company Profile

Financial Performance

In 2024, Fagron NV's revenue was 871.96 million, an increase of 14.28% compared to the previous year's 762.99 million. Earnings were 80.55 million, an increase of 14.18%.

Financial Statements

News

Record first-quarter revenue of €239 million, reflecting 14% topline growth

Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 – 7:00 AM CET Record first-quarter revenue of €239 million, reflecting 14% topline growth Fagron...

21 days ago - GlobeNewsWire

Fagron: FDA Warning Letter Creates New Entry Opportunity

Fagron: FDA Warning Letter Creates New Entry Opportunity

4 months ago - Seeking Alpha

Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook

Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 October 2024 – 7:00 AM CET Fagron reports outstanding third quarter 2024 performance with 12.1% revenue gro...

7 months ago - GlobeNewsWire

Record revenue of €209 million in first quarter reflecting 15% topline growth

Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2024 – 7:00 AM CET Record revenue of €209 million in first quarter reflecting 15% topline growth Fagr...

1 year ago - GlobeNewsWire

Continued strong third quarter performance with 11% topline growth to €191 million

Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 October 2023 – 7:00 AM CET Continued strong third quarter performance with 11% topline growth to €191 milli...

1 year ago - GlobeNewsWire

Fagron NV (ARSUF) Q2 2023 Earnings Call Transcript

Fagron NV (OTC:ARSUF) Q2 2023 Earnings Conference Call August 3, 2023 3:30 AM ET Company Participants Karen Berg - Investor Relations Rafael Padilla - Chief Executive Officer Karin de Jong - Chief Fin...

1 year ago - Seeking Alpha